Jesús Sanz
- Rheumatology top 2%
- Spondyloarthritis Studies and Treatments 41
- Rheumatoid Arthritis Research and Therapies 29
- Virology top 5%
- HIV Research and Treatment 10
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 17
- Nephrology top 5%
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis 20
-
- HIV/AIDS drug development and treatment 9
-
- HIV-related health complications and treatments 8
-
- Hepatitis C virus research 8
- Co-authors
- José Luís AndreuJordi GratacósJuan MuleroEduardo Collantes‐EstévezIgnacio de los SantosEsperanza NaredoPedro ZarcoRaimón Sanmartí
- Cited by
- RheumatologyVirologyHematology
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Jesús Sanz
86 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Rheumatology 545
- Virology 108
- Hematology 224
- Nephrology 123
- Immunology 288
Countries citing papers authored by Jesús Sanz
This map shows the geographic impact of Jesús Sanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Sanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Sanz more than expected).
Fields of papers citing papers by Jesús Sanz
This network shows the impact of papers produced by Jesús Sanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Sanz. The network helps show where Jesús Sanz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jesús Sanz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 44 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 10 | |
| 5 | 2020 | 50 | |
| 6 | 2019 | 39 | |
| 7 | 2017 | 73 | |
| 8 | 2017 | 10 | |
| 9 | 2016 | 1 | |
| 10 | 2016 | 8 | |
| 11 | 2014 | 53 | |
| 12 | 2011 | 17 | |
| 13 | 2011 | 7 | |
| 14 | 2010 | 3 | |
| 15 | 2010 | 4 | |
| 16 | 2009 | 0 | |
| 17 | Documento de consenso: Actualización del Consenso de la Sociedad Española de Reumatología sobre el uso de antagonistas del TNFα en las espondiloartritis, incluida la artritis psoriásica | 2007 | 4 |
| 18 | 2005 | 7 | |
| 19 | Fármacos de acción lenta para el tratamiento de la artrosis | 2004 | 1 |
| 20 | 1999 | 99 |
About Jesús Sanz
Jesús Sanz is a scholar working on Rheumatology, Virology and Hematology, having authored 95 papers that have together received 1.2k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (41 papers), Rheumatoid Arthritis Research and Therapies (29 papers), Psoriasis: Treatment and Pathogenesis (20 papers), Autoimmune and Inflammatory Disorders Research (17 papers), HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers), HIV-related health complications and treatments (8 papers) and Hepatitis C virus research (8 papers). The work is most often cited by research in Rheumatology (545 citations), Virology (108 citations) and Hematology (224 citations). Jesús Sanz has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include José Luís Andreu, Jordi Gratacós, Juan Mulero, Eduardo Collantes‐Estévez, Ignacio de los Santos, Esperanza Naredo, Pedro Zarco, Raimón Sanmartí, Jacqueline Usón and Ingrid Möller. Their work appears in journals such as PLoS ONE, Gut and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.